Correlation Between Werewolf Therapeutics and Exagen

Can any of the company-specific risk be diversified away by investing in both Werewolf Therapeutics and Exagen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Werewolf Therapeutics and Exagen into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Werewolf Therapeutics and Exagen Inc, you can compare the effects of market volatilities on Werewolf Therapeutics and Exagen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Werewolf Therapeutics with a short position of Exagen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Werewolf Therapeutics and Exagen.

Diversification Opportunities for Werewolf Therapeutics and Exagen

-0.62

Correlation Coefficient

Werewolf Therapeutics  Exagen

Excellent diversification

The 3 months correlation between Werewolf and Exagen is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Werewolf Therapeutics and Exagen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exagen Inc and Werewolf Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Werewolf Therapeutics are associated (or correlated) with Exagen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exagen Inc has no effect on the direction of Werewolf Therapeutics i.e., Werewolf Therapeutics and Exagen go up and down completely randomly.

Pair Corralation between Werewolf Therapeutics and Exagen

Given the investment horizon of 90 days Werewolf Therapeutics is expected to generate 1.74 times less return on investment than Exagen. In addition to that, Werewolf Therapeutics is 1.41 times more volatile than Exagen Inc. It trades about 0.01 of its total potential returns per unit of risk. Exagen Inc is currently generating about 0.03 per unit of volatility. If you would invest  289.00  in Exagen Inc on October 4, 2024 and sell it today you would earn a total of  20.00  from holding Exagen Inc or generate 6.92% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Werewolf Therapeutics  vs.  Exagen Inc

Werewolf Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Werewolf Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Exagen Inc

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Exagen Inc are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, Exagen displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Werewolf Therapeutics and Exagen

The main advantage of trading using opposite Werewolf Therapeutics and Exagen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Werewolf Therapeutics position performs unexpectedly, Exagen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exagen will offset losses from the drop in Exagen's long position.

The idea behind Werewolf Therapeutics and Exagen Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.